HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prevalence and clinical features of type 1.5 diabetes mellitus in children.

AbstractAIM:
To classify children with diabetes mellitus as type 1, 1.5 or 2, based on strict criteria, and then compare their features and treatment.
METHODS:
In this retrospective study, all children with diabetes mellitus in our clinic with antibody status available (n = 120) were reclassified as type 1, 1.5 or type 2 based on status of antibodies to the pancreas and presence of obesity and/or acanthosis nigricans, and their features compared.
RESULTS:
Sixty-four percent of type 2 patients were reclassified as type 1.5. Type 1.5 patients had significantly lower BMI SDS, blood pressure and acanthosis nigricans than type 2 patients. They had a higher insulin requirement (0.82 +/- 0.44 U/kg/day) than type 1 (0.72 +/- 0.35 U/kg/day) or type 2 (0.28 +/- 0.3 U/kg/day) patients. Total cholesterol, HDL-cholesterol, ALT and AST significantly worsened from type 1 to 1.5 to type 2 patients.
CONCLUSIONS:
Type 1.5 diabetes mellitus should be considered among obese adolescents presenting as type 2, as their clinical course is more aggressive and insulin requirement higher.
AuthorsRadhika Purushothaman, Neesha Ramchandani, Irina Kazachkova, Svetlana Ten
JournalJournal of pediatric endocrinology & metabolism : JPEM (J Pediatr Endocrinol Metab) Vol. 20 Issue 9 Pg. 981-7 (Sep 2007) ISSN: 0334-018X [Print] Germany
PMID18038707 (Publication Type: Journal Article)
Chemical References
  • Autoantibodies
  • Glycated Hemoglobin A
  • Insulin
Topics
  • Acanthosis Nigricans (complications)
  • Adolescent
  • Autoantibodies (blood)
  • Blood Pressure
  • Body Mass Index
  • Diabetes Mellitus (classification, drug therapy, immunology, physiopathology)
  • Female
  • Glycated Hemoglobin (analysis)
  • Humans
  • Insulin (therapeutic use)
  • Male
  • Retrospective Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: